Search:
Scientists are learning that even small genetic changes can make us more vulnerable to certain diseases or alter our responses to particular medicines.
Commentary on the status of personalized medicine in routine clinical care and the outlook for the future.
Researchers have found further evidence that normal genetic variations affect how the body responds to medications, but don't expect a DNA test before your next prescription.
NIGMS grantee Mary V. Relling uses gene testing to customize medications for pediatric cancer patients.
NIGMS is funding a researcher who aims to predict which patients will respond well to a class of drugs called thiopurines, which are used to treat inflammatory bowel disease and cancer, among other ailments.
New pharmacogenetic tests may help find the right dose of the right medicine for individual patients.
A review of several studies that examine genetic variations and how they influence an individual’s response to particular medications.